Tumor necrosis factor (TNF)-α-induced repression of GKAP42 protein levels through cGMP-dependent kinase (cGK)-Iα causes insulin resistance in 3T3-L1 adipocytes

J Biol Chem. 2015 Feb 27;290(9):5881-92. doi: 10.1074/jbc.M114.624759. Epub 2015 Jan 13.

Abstract

Insulin receptor substrates (IRSs) have been shown to be major mediators of insulin signaling. Recently, we found that IRSs form high-molecular weight complexes, and here, we identify by yeast two-hybrid screening a novel IRS-1-associated protein: a 42-kDa cGMP-dependent protein kinase-anchoring protein (GKAP42). GKAP42 knockdown in 3T3-L1 adipocytes suppressed insulin-dependent IRS-1 tyrosine phosphorylation and downstream signaling, resulting in suppression of GLUT4 translocation to plasma membrane induced by insulin. In addition, GLUT4 translocation was also suppressed in cells overexpressing GKAP42-N (the IRS-1 binding region of GKAP42), which competed with GKAP42 for IRS-1, indicating that GKAP42 binding to IRS-1 is required for insulin-induced GLUT4 translocation. Long term treatment of 3T3-L1 adipocytes with TNF-α, which induced insulin resistance, significantly decreased the GKAP42 protein level. We then investigated the roles of cGMP-dependent kinase (cGK)-Iα, which bound to GKAP42, in these changes. cGK-Iα knockdown partially rescued TNF-α-induced decrease in GKAP42 and impairment of insulin signals. These data indicated that TNF-α-induced repression of GKAP42 via cGK-Iα caused reduction of insulin-induced IRS-1 tyrosine phosphorylation at least in part. The present study describes analysis of the novel TNF-α-induced pathway, cGK-Iα-GKAP42, which regulates insulin-dependent signals and GLUT4 translocation.

Keywords: Adipocyte; Glucose Metabolism; Glucose Transporter Type 4 (GLUT4); Insulin Receptor Substrate 1 (IRS-1); Tumor Necrosis Factor (TNF); Type 2 Diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3-L1 Cells
  • Adaptor Proteins, Signal Transducing / genetics
  • Adaptor Proteins, Signal Transducing / metabolism*
  • Adipocytes / cytology
  • Adipocytes / drug effects*
  • Adipocytes / metabolism
  • Animals
  • CHO Cells
  • Cricetinae
  • Cricetulus
  • Cyclic GMP-Dependent Protein Kinase Type I / genetics
  • Cyclic GMP-Dependent Protein Kinase Type I / metabolism*
  • Drug Resistance
  • Glucose Transporter Type 4 / metabolism
  • HEK293 Cells
  • Humans
  • Hypoglycemic Agents / pharmacology
  • Immunoblotting
  • Insulin / pharmacology*
  • Insulin Receptor Substrate Proteins / genetics
  • Insulin Receptor Substrate Proteins / metabolism
  • Mice
  • Microscopy, Confocal
  • Phosphorylation / drug effects
  • Protein Binding
  • Protein Transport / drug effects
  • RNA Interference
  • Tumor Necrosis Factor-alpha / pharmacology*
  • Two-Hybrid System Techniques
  • Tyrosine / genetics
  • Tyrosine / metabolism

Substances

  • Adaptor Proteins, Signal Transducing
  • Gkap1 protein, mouse
  • Glucose Transporter Type 4
  • Hypoglycemic Agents
  • Insulin
  • Insulin Receptor Substrate Proteins
  • Irs1 protein, mouse
  • Slc2a4 protein, mouse
  • Tumor Necrosis Factor-alpha
  • Tyrosine
  • Cyclic GMP-Dependent Protein Kinase Type I